chrisvoncsefalvay/vaers-outcomes huggingface dataset:
- Sore left arm for about 48 hours; took Tylenol; seemed to help a little. - About 13 hours after vaccine was administered came down with severe chills and body aches; lasted about 6 hours; unable to sleep most of the night; exhausted that morning; groggy, achy, and hard to focus during the day; took a nap and got extra sleep that night; felt a little tired the following day but other than that, felt 100% (even got in a workout at the gym).
felt sweaty feeling; felt very upset; paroxysmal atrial tachycardia; pulse went up to BP of 101.; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of HYPERHIDROSIS (felt sweaty feeling), FEELING ABNORMAL (felt very upset), ATRIAL TACHYCARDIA (paroxysmal atrial tachycardia) and HEART RATE INCREASED (pulse went up to BP of 101.) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced HYPERHIDROSIS (felt sweaty feeling), FEELING ABNORMAL (felt very upset), ATRIAL TACHYCARDIA (paroxysmal atrial tachycardia) and HEART RATE INCREASED (pulse went up to BP of 101.). At the time of the report, HYPERHIDROSIS (felt sweaty feeling), FEELING ABNORMAL (felt very upset), ATRIAL TACHYCARDIA (paroxysmal atrial tachycardia) and HEART RATE INCREASED (pulse went up to BP of 101.) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Heart rate: pulse increased to BP of101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment history includes diazepam. Concomitant medications includes ''3 ''unknown drugs for high blood pressure.   Most recent FOLLOW-UP information incorporated above includes: On 11-Feb-2021: process with initial
The symptoms started on 6/28/2019.  Swelling, redness, hot, and painful to touch and to move at my upper left arm.  It was painful when lifted my arm up, down, reached front and back for a week.  Even though all the symptoms subsided after I applied ice packs couple of times a day, my upper left is still not the same.  I feel there is block at bellow the left deltoid muscle every time I lift or raise my arm, and reach front and back.  I feel I my left upper arm is going to break and  feel hurt  with all these activities above.    I waited until now to file a report because I thought my will get better in times but it has been 3 months, the pain is restricted me to move my arm freely.
couldn't sleep the night; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (couldn't sleep the night) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (couldn't sleep the night). At the time of the report, INSOMNIA (couldn't sleep the night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided. No concomitant medications were reported.   Reporter did not allow further contact
Patient experienced significant bruising going on several days. Her skin was hot to the touch but then it resolved.
Sore arm at injection site by 8:30pm on 4/28/2021. Woke up on 4/29/2021 at 7am and spent all day feeling lethargic, muscle stiffness, and arm remained sore.
Information has been received from a medical assistant referring to an 11 year old female patient without pertinent medical history and drug reactions/allergies. On 16-FEB-2015, the patient was vaccinated with the first dose of GARDASIL in her right deltoid (dose not provided, lot number reported as K004204, expiration date 12-JAN-2017) while lying down. The patient also administered MCV4 (Sanofi) and TDAP (Sanofi) (dose, route and lot number not provided) on the same date in a different extremity. Before the patient sat up, she experienced minor seizure like activity in the office of physician. Treatment from physician was to keep patient lying down for an unspecified length of time, water, candy and observation for 30 minutes. No lab diagnostics were performed. The outcome of convulsion was reported as recovered/resolved on 16-FEB-2015. Additional information has been requested.
Pt played around weeds 25MAY91&26MAY91.27MAY91 devl generalized mac pap blotchy rash that itched on legs,chest,back,face&ears which swelled;had fever&nausea;Rash also on palms of hands 30MAY&31MAY91;9Jun91 at clinic-tick removed& inc rash
Patient received a pediatric Pfizer dose instead of an adult dose of Pfizer for his first dose received. This was an oversight completely as vaccine was appropriately diluted and administered per practice of a double check.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old male patient received BNT162b2 (BNT162B2), on 26May2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 38 years, in right arm for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Patient received Other medication in 2 weeks. No Known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever 101.4F) and TINNITUS (really loud ringing in her ears and if she moved, it was buzzing) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever 101.4F) and TINNITUS (really loud ringing in her ears and if she moved, it was buzzing). At the time of the report, CHILLS (Chills), PYREXIA (Fever 101.4F) and TINNITUS (really loud ringing in her ears and if she moved, it was buzzing) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact.
p/vax runny nose; swollen glands;MD fine rash over body w/some areas blotchy, red, itchy rash; T101; swollen glands;could not locate parent to find out results of MD visit; clinic states pt saw MD 4/23; dx URI
4/18/2021 - injection site red swollen tender chilly feeling 4/19/2021 chills, H.A. SOB 4/20/2021 redness @ injection site resolving. H.A 4/21/2021 - redness @ injection site
I couldn't breath, cough, fatigued and was pregnant at the time. It lasted out 3 or 4 weeks. I am still having some difficulty breathing.
Patient came into the pharmacy this morning because she wanted to show me a rash that she had all over her stomach and how her injection site had swollen on her Left arm.  She wanted to know what she could do about it as well as she informed me that yesterday she had a rapid heartbeat that felt like anxiety but, noted that she wasn't anxious about anything.  She was not complaining about that today, only the rash, so I suggested her to try Benadryl 50mg q 6-8 h and warned her of drowsiness.  I also told her that if there is no improvement by tomorrow to go to the immediate care.  Today is Saturday, so we would not be able to contact her primary doctor until Monday and I don't want her waiting that long if there is no improvement, or worsening symptoms, today or tomorrow. I advised Benadryl first because it's been 2 days and today aside from the rash, she is seems fine otherwise.  She mentioned the rapid heartbeat as only a yesterday symptom and not today.  If she was having that today, I would have sent her directly to the immediate care.  I will follow up with her PCP on Monday to make them aware.  This patient has had high dose flu shots from the same manufacturer in the past and been fine with no previous adverse reactions.  The only difference this year would be the quadrivalent versus trivalent vaccine.  I am marking Question 21 as she had a visit to a healthcare professional since she came into the pharmacy today.
Fever, body aches, soreness and some swelling at injection site; by 9:00 sore eyes, light flashes before eyes, weakness, dizziness with difficulty standing upright; by 3:00 am fever diminished, with drenching sweat, mild stomachache; by 7:00 am all symptoms gone except sore arm and mild stomachache.
BRIEF OVERVIEW: Discharge Provider: Private Primary Care Provider: None Physician, DO Admission Date: 7/23/2022 Discharge Date:  07/26/2022  PRESENTING PROBLEM: Nephrostomy tube displaced (HCC) [T83.022A] Acute kidney injury (HCC) [N17.9] Fall, initial encounter [W19.XXXA]   HOSPITAL COURSE: 82 y.o. male with a PMHx of prostate cancer, PE, TIA, HTN, and recent COVID-19 diagnosis (requiring 2 L oxygen), reportedly contracted from staff at facility who presented after a fall at said facility.  Per hospice nursing staff, patient got out of bed and was tangled in devices.  Patient was confused and staff were concerned that he struck his head on the bedside table.  Hospice nursing staff was contacted by the assisted living facility and patient was discharged from hospice to transfer to the emergency department for treatment.  At presentation patient was confused and unable to corroborate, but patient's daughter corroborated the story she heard over the phone.     Regarding patient's prostate cancer, he was enrolled in hospice with local Hospice on 07/07/2022 as patient no longer wished to pursue treatment.  His prostate cancer is causing obstruction of his right ureter and resultant hydronephrosis.  He required nephrostomy tube placement in January of 2022 to relieve this obstruction. The tube was replaced in April per protocol, then developed a leak and was replaced again in May. In June, it became dislodged and needed to be replaced before becoming dislodged on 07/20/2022 and, yet again, being replaced.  While in hospital, basic laboratory work and imaging were performed.  Workup demonstrated worsening kidney function, ultimately found to be secondary to hydronephrosis from mal-positioned nephrostomy tube.  Imaging of the head was negative for acute process.  Patient was admitted to the hospital with subsequent repositioning of nephrostomy tube.  A goals of care discussion was held with family, and was determined that the patient would not want aggressive measures and would most prefer  return to hospice now that nephrostomy tube was causing no distress.
Information regarding PREVNAR 13 was received from a nurse regarding an unknown number of patients who experience injection site redness and swelling at the injection site. The patients received a dose on an unspecified date. The patients experienced injection site redness and swelling at the injection site on unknown dates in 2010. No additional information was available at the time of this report.
Patient reports tingling in Left arm following vaccine administration. Tingling went from site of injection down arm to 4th and 5th fingers on left hand. Declines any headache, dizziness, numbness. Can feel touch to hand/fingers
Felt fine after shot. Around 3:45pm she was sitting on the sofa, saw a flash of light (which quickly disappeared) and she started vomiting.  No fever or muscle aches. She felt better after getting sick and has been drinking/eating light meals.
right hand knuckles are red and swollen; painful joints all over; headache; muscle aches; chills and rigors; severe fatigue; right hand knuckles are red and swollen; Fever 101.5F; This is a spontaneous report from a contactable other healthcare professional. A 59-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN6198), via unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hypothyroidism, hyperparathyroidism and HTN (as reported). The patient previously received diphenhydramine (MANUFACTURER UNKNOWN) and unspecified stains for unspecified indication and experienced drug allergy. Concomitant medications included irbesartan (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID), bisoprolol (MANUFACTURER UNKNOWN), mometasone furoate (ASMANEX) and salbutamol (ALBUTEROL) for unknown indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN6198), via unspecified route of administration in the left arm on 05Mar2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID19. On 23Mar2021 at 22:45, the patient experienced fever 101.5F, chills and rigors, painful joints all over, right hand knuckles were red and swollen, headache, muscle aches all over and severe fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of fever 101.5F, chills and rigors, painful joints all over, right hand knuckles were red and swollen, headache, muscle aches all over and severe fatigue was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Continued tenderness around injection site after second round of Hep B vaccine that was administered by a nurse from the  Health Department at School. Soreness when tapped/touched/laid on.
Information has been received from a consumer, for the Pregnancy Registry for GARDASIL concerning herself, a 26 year old female, who on 12-FEB-2008 was vaccinated with her first dose of GARDASIL (lot# not reported). Concomitant therapy included Zoloft. On 18-FEB-2008 the patient found out she was about 6 weeks pregnant. Her LMP was estimated to be 06-JAN-2008 with a due date of 12-OCT-2008. The patient had a positive home pregnancy test. Her outcome was not reported. Follow up information was received from the consumer and the office nurse, for GARDASIL,  Pregnancy Registry product. The office nurse reported that they did not even know the patient was pregnant. The patient reported that she went into spontaneous labor, but her labor didn't progress fully, and she had a cesarean section. On 22-OCT-2008, the patient delivered a health baby boy (8 pounds, 13 ounces) with no problems. At the time of reporting, the patient recovered completely from the C-section, and had no complications. Upon internal review, cesarean section due to labor not progress fully was determined to be an other important medical event. Additional information is not expected.
Her immune system went down to 300. This year it went up to 900; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported for a female patient of an unspecified age that she received bnt162b2 (BNT162B2, Formulation: Solution for injection), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The medical history included COPD (chronic obstructive pulmonary disease) (She have COPD for a year and a half) from an unknown date. The historical vaccine included received bnt162b2 (BNT162B2), as DOSE 1, SINGLE for covid-19 immunisation. The patient received the second dose of the Pfizer-BioNTech COVID-19 Vaccine in Mar2020 and had been receiving immunity injections monthly. She said that she was receiving a drug caller Gammagard as an IgG infusion. She had COPD for a year and a half, and her doctors performed test and wanted her to her a trial. She had been in the hospital for 2 or 3 weeks for a few years and she took blood test because her immune system went down to 300 on an unspecified date (medically significant). This year it went up to 900 on an unspecified date in 2021 (medically significant). She wanted to get the third dose and wanted to know if it was the same as the first and second dose. She was asking how long she should wait to get the third dose. She was asking how long the interval should be for the vaccine and her infusion. She said that she did some research and found out that she had to wait 3 days. Response: Provided information from internal document. Referred to HCP. The patient underwent lab tests and procedures which included blood test: Unknown results on an unspecified date, immunology test was noted to be 300 went down on an unspecified date, immunology test was noted to be 900 in 2021 went up. The outcome of the event was unknown.  Follow-up was being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
I got COVID after Dose 3. I experienced a a bad cold, didn't loose taste to smell, nasty cough, and felt very ill lasted four days.
On day eight following vaccination itching on upper arm at site.  Day nine redness at site. Redness and itching expanded down arm.  Day 12  swelling in arm and lymph nodes?? above crease in left arm swollen.  One slightly and the other golf ball size.  Contacted doctor on day 13 (Friday morning) . Due to weather conditions advised to see him on the following Monday (today day 16) if not improved.  Currently the redness and itching has stopped but swelling in one of the lymph nodes is still visible but much better than before.  My concern is about worse reaction to second vaccine and if I should  receive second vaccine in same arm.
Sore arm; Fatigue; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via an unspecified route of administration in the left arm on 07Apr2021 at 15:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issue. The patient had no known allergies to medications, food or other products. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 17Mar2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 08:00, the patient experienced sore arm, fatigue, chills and nausea. The events did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events sore arm, fatigue, chills and nausea. The clinical outcome of the events sore arm, fatigue, chills and nausea were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
My hair is falling out, Hair loss started maybe a week after first shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (My hair is falling out, Hair loss started maybe a week after first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (My hair is falling out, Hair loss started maybe a week after first shot). At the time of the report, ALOPECIA (My hair is falling out, Hair loss started maybe a week after first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information were provided.  Concomitant product use was not provided by the reporter.
Always had BP 120/80. After vaccines BP 150/95 average for days, now even with medication average 145/ 85
Sore, tender arm for approximately 48 hours. Local bruising for about 3-4 days. Chills after 24 hours, body ache, redness.
Pateint presented with an approximately 4 to 6 inch in diameter rash/welt in upper left extremity. It was distal and medial to the injection site in the left deltoid. She also stated the area to be more painful than expected.
Intensity her nerve pain per patient and possible suspected Guillain-Barre Syndrome. Per her P.C.P. (according to the patient).
Information has been received from a nurse concerning a female who on approximately 24-DEC-2007 was vaccinated with her first dose of GARDASIL (lot numbers not provided). It was reported that a "patient who received the GARDASIL (lot numbers not provided) had visited the physician a couple of days after being vaccinated because she had developed  case of warts." The patient's warts persisted. No further information is available. This is in follow-up to report(s) previously submitted on 3/14/2008.  Information has been received from a nurse concerning a female who on approximately 24-DEC-2007 was vaccinated with her first dose of GARDASIL (lot numbers not provided).  The patient received the second dose of GARDASIL (lot numbers not provided) in February 2008.  It was reported that a "patient who received the GARDASIL (lot numbers not provided) had visited the physician a couple of days after being vaccinated because she had developed an extensive case of warts."  Information received during follow up indicated that the onset date was 01-Feb-2008.  The patient's warts persisted.  No further information is available.
UTI; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced URINARY TRACT INFECTION (UTI). At the time of the report, URINARY TRACT INFECTION (UTI) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was Antibiotics for UTI.